Announcement caused the price on the Nasdaq only to inch up with no volume, I was surprised as this has been on my watch list. The announcement is extremely positive but no reaction? I was thinking was it reporting season and tech on the nose in the states so analysts dismissed it. The lack of understanding of Amyloid reduction and its implications or is it the probable 5 year lag from trial to drug? One certainly to watch for signs of buying.
Regards RM
media, page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(14.3%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $11.18K | 3.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 52064257 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126697935 | 22 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |